[1] McDonough C M, Harris-Hayes M, Kristensen M T, et al. Physical therapy management of older adults with hip fracture[J]. J Orthop Sports Phys Ther, 2021, 51(2): CPG1-CPG81.
[2] Kluger M T, Skarin M, Collier J, et al. Steroids to reduce the impact on delirium (STRIDE): a double-blind, randomised, placebo-controlled feasibility trial of pre-operative dexamethasone in people with hip fracture[J]. Anaesthesia, 2021, 76(8): 1031-1041.
[3] Pang Y, Li Y T, Zhang Y G, et al. Effects of inflammation and oxidative stress on postoperative delirium in cardiac surgery[J]. Front Cardiovasc Med, 2022, 9: 1049600.
[4] Hughes C G, Mailloux P T, Devlin J W, et al. Dexmedetomidine or propofol for sedation in mechanically ventilated adults with sepsis[J]. N Engl J Med, 2021, 384(15): 1424-1436.
[5] Ohta Y, Miyamoto K, Kawazoe Y, et al. Effect of dexmedetomidine on inflammation in patients with sepsis requiring mechanical ventilation: a sub-analysis of a multicenter randomized clinical trial[J]. Crit Care, 2020, 24(1): 493.
[6] Su X, Meng Z T, Wu X H, et al. Dexmedetomidine for prevention of delirium in elderly patients after non-cardiac surgery: a randomised, double-blind, placebo-controlled trial[J]. Lancet, 2016, 388(10054): 1893-1902.
[7] Skrobik Y, Duprey M S, Hill N S, et al. Low-dose nocturnal dexmedetomidine prevents ICU delirium. A randomized, placebo-controlled trial[J]. Am J Respir Crit Care Med, 2018, 197(9): 1147-1156.
[8] Maldonado J R. Acute brain failure: pathophysiology, diagnosis, management, and sequelae of delirium[J]. Crit Care Clin, 2017, 33(3): 461-519.
[9] van Munster B C, Korse C M, de Rooij S E, et al. Markers of cerebral damage during delirium in elderly patients with hip fracture[J]. BMC Neurol, 2009, 9: 21.
[10] Clemmesen C G, Tavenier J, Andersen O, et al. Methylprednisolone and inflammatory stress response in older people undergoing surgery for hip fracture: a secondary analysis of a randomized controlled trial[J]. Eur Geriatr Med, 2019, 10(6): 913-921.
[11] Venn R M, Bradshaw C J, Spencer R, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit[J]. Anaesthesia, 1999, 54(12): 1136-1142.
[12] Mei B, Li J, Zuo Z Y. Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy via central α2A adrenoceptor[J]. Brain Behav Immun, 2021, 91: 296-314.
[13] Cui J J, Gao M T, Huang H Q, et al. Dexmedetomidine improves lung function by promoting inflammation resolution in patients undergoing totally thoracoscopic cardiac surgery[J]. Oxid Med Cell Longev, 2020, 2020: 8638301.
[14] Fan W, Yang H K, Sun Y, et al. Comparison of the pro-postoperative analgesia of intraoperative dexmedetomidine with and without loading dose following general anesthesia: a prospective, randomized, controlled clinical trial[J]. Medicine (Baltimore), 2017, 96(7): e6106.
[15] Lee J, Hwang H W, Jeong J Y, et al. The effect of low-dose dexmedetomidine on pain and inflammation in patients undergoing laparoscopic hysterectomy[J]. J Clin Med, 2022, 11(10): 2802.
[16] Moon J, Yoo Y C, Kim M H, et al. Administration of low-dose dexmedetomidine did not affect acute inflammatory response after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: a double-blind randomized controlled trial[J]. J Clin Med, 2021, 10(14): 3145.
[17] Jiang Y X, Xia M Z, Huang Q, et al. Protective effect of dexmedetomidine against organ dysfunction in a two-hit model of hemorrhage/resuscitation and endotoxemia in rats[J]. Braz J Med Biol Res, 2019, 52(3): e7905.
[18] Sanson G, Khlopenyuk Y, Milocco S, et al. Delirium after cardiac surgery. Incidence, phenotypes, predisposing and precipitating risk factors, and effects[J]. Heart Lung, 2018, 47(4): 408-417.
[19] Sun Y M, Zhu S N, Zhang C, et al. Effect of low-dose dexmedetomidine on sleep quality in postoperative patients with mechanical ventilation in the intensive care unit: a pilot randomized trial[J]. Front Med (Lausanne), 2022, 9: 931084.
|